XML 286 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statement Of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from/(used in) operating activities      
Profit after tax for the period $ 3,646 $ 1,722 $ 6,575
Non-cash items      
Depreciation and amortisation 4,552 3,960 2,808
Depreciation of lease assets 210 179 140
Change in fair value of derivative financial instruments 352 349 960
Net finance costs 145 34 12
Tax expense 723 1,551 2,599
Exploration and evaluation written off 9 77 164
Impairment losses   1,917  
Impairment reversals     (900)
Restoration movement 199 147 272
Gain on disposal of property, plant and equipment (including revaluation gain) (238)   (494)
Movement in onerous contracts provision     (245)
Other (135) (226) (254)
Changes in assets and liabilities      
(Increase)/decrease in trade and other receivables (301) 107 (77)
Increase in inventories (161) (31) (146)
Increase/(decrease) in provisions 3 (114) 131
Decrease in lease liabilities     (31)
Increase in other assets and liabilities (45) (736) (961)
Increase/(decrease) in trade and other payables 175 (135) 184
Cash generated from operations 9,134 8,801 10,737
Purchases of shares and payments relating to employee share plans (81) (57) (45)
Interest received 183 264 108
Dividends received 12 20 19
Borrowing costs relating to operating activities (41) (26) (21)
Income tax and PRRT paid (2,555) (2,916) (1,218)
Payments for restoration (805) (447) (263)
Receipts/(payments) for hedge collateral   506 (506)
Net cash from operating activities 5,847 6,145 8,811
Cash flows from/(used in) investing activities      
Cash (paid)/received on business combination, net of cash acquired (1,896)   1,082
Payments for capital and exploration expenditure (4,902) (5,291) (3,136)
Payments for asset acquisition, net of cash acquired (1,042)    
Reimbursements received from external parties for capital expenditure 155    
Borrowing costs relating to investing activities (369) (311) (287)
Advances to other external entities     (48)
Proceeds from disposal of non-current assets 2,307 19 132
Funding of equity accounted investments 0 (2) (8)
Net cash used in investing activities (5,747) (5,585) (2,265)
Cash flows from/(used in) financing activities      
Proceeds from borrowings 5,114    
Repayment of borrowings (169) [1],[2] (284) [1] (283)
Borrowing costs relating to financing activities (2) (4) (18)
Repayment of the principal portion of lease liabilities (278) (340) (248)
Borrowing costs relating to lease liabilities (15) (21) (10)
Purchases of shares and payments relating to Dividend Reinvestment Plan     (144)
Contributions to non-controlling interests (100) (98) (98)
Dividends paid (2,449) (4,253) (2,558)
Net payments from share issuance     (5)
Net cash from/(used in) in financing activities 2,101 (5,000) (3,364)
Net increase/(decrease) in cash held 2,201 (4,440) 3,182
Cash and cash equivalents at the beginning of the period 1,740 6,201 3,025
Effects of exchange rate changes (18) (21) (6)
Cash and cash equivalents at the end of the period $ 3,923 $ 1,740 $ 6,201
[1] Included in cash flows classified within financing activities in the consolidated statement of cash flows.
[2] Refer to Note B.7 for details on asset acquisitions. The debt acquired through asset acquisitions was repaid during the year.